|
2016
|
Invention
|
Mirna compositions for the treatment of mature b-cell neoplasms.
Provided herein are composition... |
|
|
Invention
|
Mirna compositions for the treatment of mature b-cell neoplasms. Provided herein are compositions... |
|
2015
|
Invention
|
Method of predicting or prognosticating neurological performance in patients who have suffered a ... |
|
|
Invention
|
Micellar nanoparticles containing antitumoral glycosides. The present invention is related to mic... |
|
|
Invention
|
Aav vectors for the treatment of ischemic and non-ischemic heart disease. The present invention r... |
|
2014
|
Invention
|
Stable episomes based on non-integrative lentiviral vectors. The invention relates to non-intregr... |
|
|
Invention
|
Method to screen for selective peptides that inhibit the biological activity of calcineurin.
Th... |
|
|
Invention
|
Oral formulation for the treatment of cardiovascular diseases. The present invention relates to a... |
|
2013
|
Invention
|
Lxvp-mediated calcineurin inhibition in macrophages. The present invention refers to a compositio... |
|
|
Invention
|
Nucleotide sequence motifs directing nucleic acid location to extracellular vesicles.
The presen... |
|
|
Invention
|
Nucleotide sequence motifs directing nucleic acid location to extracellular vesicles. The present... |
|
|
Invention
|
Beta-3 adrenoceptor agonists for the treatment of pulmonary hypertension. The invention relates t... |
|
|
Invention
|
Nanoparticles coated with gelatin. The invention relates to nanoparticles comprising a core and a... |
|
|
Invention
|
Marker for determining the therapeutic potential of mesenchymal stem cells, an inhibitor of the m... |
|
2012
|
Invention
|
Mt1-mmp substrates as biomarkers of inflammatory angiogenesis. MT1-MMP substrates as biomarkersof... |
|
|
Invention
|
Caveolin-1 in tumor-associated fibroblasts as biomarker for tumor progression. The present invent... |
|
2011
|
Invention
|
Compounds for treating cardiac damage after ischaemia/reperfusion. The present invention relates ... |
|
|
Invention
|
Method to inhibit the biological activity of calcineurin with selective peptides.
The invention ... |
|
|
Invention
|
Use of anticalcineurin compounds for the treatment of pathologies involving ocular neovascularisa... |
|
2010
|
Invention
|
Bioactive surface capable of genetically modifying biological cells or tissues and use thereof.
... |
|
|
Invention
|
Bioactive surface capable of genetically modifying biological cells or tissues and use thereof. T... |
|
|
Invention
|
Use of cd98 as endometrial receptivity marker. The invention relates to the use of CD98 as endome... |
|
2009
|
Invention
|
Composition comprising silibinin at determined concentrations and combined preparation comprising... |
|
|
Invention
|
Anti-tumour compounds. The invention provides a series of compounds with labdane-type diterpenoid... |
|
|
Invention
|
Capsule for the prevention of cardiovascular diseases. The invention relates to a capsule for the... |
|
2006
|
Invention
|
Methods of using the calcineurin a variant cna-beta 1.
The present invention relates to an inhib... |
|
2005
|
Invention
|
Peptides, nucleotide sequences and cnalinker13 cells and applications thereof. The invention rela... |
